Examples of Boehringer in a sentence
Rhone-Poulenc Pharma [1996] ECR I-3671; Case C-143/00, Boehringer Ingelheim KG v.
Brenda W.J.H. Penninx (BWJHP) has received research funding (non-related to the work reported here) from Jansen Research and Boehringer Ingelheim.
Sigrun Halvorsen: Speaker fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Merck, Sanofi.
On information and belief, BIFI has manufactured and/or will manufacture the Boehringer aBLA Product once it is approved by the FDA.
Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or pub- lication of this article: Maddalena Lettino: speaker andconsulting fees for AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Aspen, Pfizer, Eli Lilly, Daiichi Sankyo, Sanofi.
N.R. has received consultancy fees from Roche; has participated in speakers bureaus for Abbott, AbbVie, Amgen, Astellas, Bristol Myers-Squibb, Boehringer, Celgene, CrescendoBio, EMDSerono, Italfarmaco, Janssen, Medimmune, Novartis, Novonordisk, Pfizer, Sanofi, Reumatic.com, Servier, Sinergie and Takeda and has received research funding from Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Novartis, Pfizer, Roche, Sanofi Aventis and Schwarz Biosciences.
Disclosure summary:Dr. Benfield reports grants from Novo Nordisk Foundation, grants from Simonsen Foundation, grants and personal fees from GSK, grants and personal fees from Pfizer, personal fees from Boehringer Ingelheim, grants and personal fees from Gilead, personal fees from MSD, grants from Lundbeck Foundation, grants from Kai Hansen Foundation, personal fees from Pentabase A/S, outside the submitted work.
She has advised on multiple antitrust matters for Caremark, Cigna, UPMC, Duke University, Yale-New Haven Health System, Centura, SSM Health, UnityPoint, Abbot Laboratories, Boehringer Ingelheim, Sumitomo Dainippon Pharmaceuticals and Bon Secours Mercy Health.Bevin frequently writes and speaks on antitrust and competition issues, particularly in the healthcare field.
The right to sell OTC Zantac in the United States later passed to Boehringer Ingelheim Pharmaceuticals and then to Sanofi.
Boehringer Ingelheim Contract Manufacturing Organization Services Product and SolutionsTable 45.